2.50
-0.21 (-7.75%)
Previous Close | 2.71 |
Open | 2.62 |
Volume | 367,607 |
Avg. Volume (3M) | 655,866 |
Market Cap | 88,223,504 |
Price / Sales | 243.53 |
Price / Book | 6.57 |
52 Weeks Range |
Diluted EPS (TTM) | -0.510 |
Total Debt/Equity (MRQ) | 2.51% |
Current Ratio (MRQ) | 10.57 |
Operating Cash Flow (TTM) | -13.97 M |
Levered Free Cash Flow (TTM) | -8.90 M |
Return on Assets (TTM) | -55.72% |
Return on Equity (TTM) | -117.05% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Mixed |
Medical Devices (Global) | Mixed | Mixed | |
Stock | Monogram Technologies Inc. | Bullish | - |
AIStockmoo Score
Analyst Consensus | 3.5 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 4.0 |
Average | 2.00 |
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. |
|
Sector | Healthcare |
Industry | Medical Devices |
% Held by Insiders | 33.90% |
% Held by Institutions | 4.21% |
Ownership
Name | Date | Shares Held |
---|---|---|
New Harbor Financial Group, Llc | 31 Dec 2024 | 29,348 |
Fiduciary Family Office, Llc | 31 Dec 2024 | 29,348 |
52 Weeks Range | ||
Median | 5.40 (116.00%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Roth MKM | 18 Mar 2025 | 5.40 (116.00%) | Buy | 3.43 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |